Showing results (41-50 of 100) with videos related to

Sort By:
Pageof 10
Geburtshilfe Und Frauenheilkunde|March 1, 1987
[Therapeutic and prognostic results of a prospective multicenter ovarian cancer study of FIGO stages I and II]P Sevelda, E Gitsch, C Dittrich, et al.
Deutsche Medizinische Wochenschrift (1946)|December 22, 1992
[Adjuvant hormonal therapy in lymph node-negative breast carcinoma patients in the postmenopause]C Kurz, C Scholten, C Zielinski, et al.
Gynecologic Oncology|November 25, 1998
Amplification and expression of the c-erbB-2 oncogene in Müllerian-derived genital-tract tumorsM Manavi, A Berger, E Kucera, et al.
Archives of Gynecology and Obstetrics|January 1, 1995
The relation between depth of trophoblastic invasion and beta-HCG levels in tubal pregnanciesM Klein, A Graf, H Kiss, et al.
Histopathology|December 1, 2004
Presence of nanobacteria in psammoma bodies of ovarian cancer: evidence for pathogenetic role in intratumoral biomineralizationG Hudelist, C F Singer, E Kubista, et al.
International Journal of Cancer|July 17, 1995
Microvessel density and vessel invasion in lymph-node-negative breast cancer: effect on recurrence-free survivalA Obermair, C Kurz, K Czerwenka, et al.
Anticancer Research|November 20, 2001
Prognostic parameters in carcinosarcomas of the uterus: a clinico-pathologic studyB Bodner-Adler, K Bodner, A Obermair, et al.
British Journal of Cancer|November 1, 1996
Presence of endothelial calcium-dependent nitric oxide synthase in breast apocrine metaplasiaW Tschugguel, W Knogler, K Czerwenka, et al.
Breast Cancer Research and Treatment|January 1, 1996
Human papilloma virus DNA: a factor in the pathogenesis of mammary Paget's disease?K Czerwenka, F Heuss, J W Hosmann, et al.
Anticancer Research|January 1, 1997
EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patientsJ Fischer-Colbrie, A Witt, H Heinzl, et al.
Pageof 10